Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranolazine Extended-Release in Chronic Stable Angina (Phase II, China)
CTR20131084Phase 2Active
- Sponsor
- Hainan Sihuan Cardiovascular and Cerebrovascular Drug Research Institute
- Start
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ranolazine in angina pectoris, sponsored by Hainan Sihuan Cardiovascular and Cerebrovascular Drug Research Institute. Started Nov 2013; status: active.
02
Drugs
ranolazine
03
Conditions
angina pectoris
Beyond the preview
Go deeper on CTR20131084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131084.